Delirium, Agitation/Sedation, Pain and Dyspnea in Respiratory Intensive Care Unit (NIVILIUM)
NIVILIUM
Longitudinal Assessment of Delirium, Agitation/Sedation, Pain and Dyspnea in Patients Admitted to Respiratory Intensive Care Unit for Acute Respiratory Failure (NIVILIUM)
1 other identifier
observational
92
1 country
1
Brief Summary
Non-Invasive Mechanical Ventilation (NIV) has been increasingly used in the treatment of acute respiratory failure. Notwithstanding failure rates still remains high, ranging from 5% to 60%. The onset of delirium, agitation, pain and dyspnea may contribute to reduce the success rate of non invasive ventilation treatment. The aim of this study is to assess the incidence and impact of delirium, agitation, pain and dyspnea on clinical outcomes in a population of patient admitted to Respiratory Intensive Care Unit undergoing Non-Invasive Mechanical Ventilation for Acute Respiratory Failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 14, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedMay 10, 2023
May 1, 2023
1 year
March 14, 2019
May 9, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Incidence of delirium
The onset of delirium will be assessed through the Confusion Assessment Method for Intensive Care Unit 7 scale, ranges 0-7, values \> 2 indicate the presence of delirium
7 days from Respiratory Intensive Care Unit admission
Incidence of agitation
The onset of delirium will be assessed through the Richmond Agitation Sedation Scale ranges +4 to -5, values \> 0 indicate the presence of agitation, values \< 0 indicate the presence of sedation
7 days from Respiratory Intensive Care Unit admission
Incidence of pain
The onset of delirium will be assessed through the Behavioral Pain Scale, ranges 3-12, values \> 4 indicate the presence of pain
7 days from Respiratory Intensive Care Unit admission
Incidence of dyspnea
The onset of delirium will be assessed through the Borg scale, ranges 0-10, values \> 0 indicate the presence of dyspnea
7 days from Respiratory Intensive Care Unit admission
Secondary Outcomes (4)
The impact of delirium on Non Invasive Ventilation Success
30 days from Respiratory Intensive Care Unit admission
The impact of agitation on Non Invasive Ventilation Success
30 days from Respiratory Intensive Care Unit admission
The impact of pain on Non Invasive Ventilation Success
30 days from Respiratory Intensive Care Unit admission
The impact of dyspnea on Non Invasive Ventilation Success
30 days from Respiratory Intensive Care Unit admission
Interventions
To systematically assess the onset of delirium, quantify the level of agitation/sedation, estimate the grade of pain and survey the level of dyspnea in patients undergoing non invasive mechanical ventilation
Eligibility Criteria
Patients with acute respiratory failure admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena undergoing non invasive mechanical ventilation not known for psychiatric disease or dementia
You may qualify if:
- patients with acute respiratory failure admitted to the Respiratory Intensive Care Unit of the University Hospital of Modena undergoing non invasive mechanical ventilation
You may not qualify if:
- age lower than 18
- Glasgow Coma Scale lower than 10 within 24 hours from Respiratory Intensive Care Unit admission
- need for immediate orotracheal intubation
- pregnancy
- previously established psychiatric disease or dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliero Universitaria Policlinico di Modena
Modena, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 14, 2019
First Posted
March 19, 2019
Study Start
August 1, 2019
Primary Completion
August 1, 2020
Study Completion
January 1, 2025
Last Updated
May 10, 2023
Record last verified: 2023-05